期刊文献+

丙肝病毒F基因对c-myc转录调控作用 被引量:1

Effect of HCV-F gene on transcription activation of c-myc promoter
原文传递
导出
摘要 目的观察丙型肝炎病毒(HCV)F基因对c-myc启动子转录活性的影响,探讨HCV F基因表达产物参与肝细胞癌变的机制。方法构建c-myc启动子的萤光素酶报告质粒,与HCV-F和HCV-C的表达质粒共转染人肝癌细胞系HepG 2细胞,测定萤光素酶的活性,分析HCV-F、HCV-C对c-myc启动子转录活性的影响。结果在HepG 2细胞中,HCV-C对c-myc启动子的转录具有明显的促进作用,启动子的转录活性比对照组提高约7倍,且在HCV-C的剂量为2~10μg时,其作用具有剂量依赖性;HCV-F对c-myc启动子转录活性也具有激活作用,在剂量为2μg时,启动子的转录活性约为对照组的3倍,c-myc启动子对HCV-F的剂量依赖激活作用不明显。结论 HCV-F相比HCV-C不能有效的调节c-myc启动子转录活性,HCV-C起主要的调节功能。 Objective To observe the effect of hepatitis C virus-F(HCV-F) gene on transcription activition of c-myc promoter and to explore the role of HCV-F on pathogenesis of hepatocarcinogenesis.Methods The luciferase reporter plasmids of c-myc promoter were constructed and cotransfected into HepG 2 cells with HCV-F and HCV-C expression plasmids.The transactivition of c-myc promoter was assayed by luminometer.Results HCV-C exhibited a distinct promotion activity to c-myc promoter,with a seven-folds increase of c-myc promoter transactivity compared to that of the control group.HCV-F showed less promotion activity and enhanced luciferase activity about three-folds increse of c-myc promoter.At a range of 2 to 10 μg,the enhancement of c-myc promoter was observed to be dose-dependent only with HCV-C not HCV-F.ConclusionHCV-F exhibits less promotion activity for c-myc promoter than HCV-C,which does not posses all functions of HCV-C protein.
出处 《中国公共卫生》 CAS CSCD 北大核心 2010年第12期1508-1510,共3页 Chinese Journal of Public Health
基金 国家自然科学基金面上项目(30972628) 江苏省自然科学基金面上项目(BK2010112) 江苏省高校自然科学研究项目(09KJB330001) 中国博士后科学基金项目(20090451569) 江苏省博士后科研资助计划项目(0901060C)
关键词 丙型肝炎病毒(HCV) F基因 c-myc启动子 萤光素酶 hepatitis C virus(HCV) F gene c-myc promoter luciferase
  • 相关文献

参考文献4

二级参考文献46

  • 1Ru-Fu Chen, Zhi-Hua Li, Sheng-Quan Zou and Ji-Sheng Chen Guangzhou, China Department of Hepatobiliary Surgery,Hospital of Zhongshan University, Guangzhou 510120, China ,Department of Surgery,Tongji Hospital, Wuhan 430030, China.Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma[J].Hepatobiliary & Pancreatic Diseases International,2005,4(1):71-74. 被引量:9
  • 2张志培,王文亮,王文勇,成胜权,杨彤涛,邓中荣,王丽,李擒龙.HCV肝炎肝硬化中核心蛋白、p14^(ARF)和p21^(WAF1)的表达[J].临床与实验病理学杂志,2005,21(2):147-150. 被引量:2
  • 3张志培,王文亮,邓中荣,王文勇,李擒龙,王丽.HCV核心蛋白,p53,Mdm2,p14^(ARF)在HCV肝炎肝硬化的表达及相关性[J].第四军医大学学报,2005,26(12):1097-1100. 被引量:8
  • 4Kunkel M,Watowich SJ.Biophysical characterization of hepatitis C virus core protein:implications for interactions within the virus and host[J].FEBS Letter,2004,557(1 ~3):174 ~180.
  • 5Miyoshi H,Fujie H,Shintani Y,et al.Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression[J].J Hepatol,2005,43 (5):757~ 763.
  • 6Hainaut P,Pfeifer GP.Patterns of p53 G--> T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke[J].Carcinogenesis,2001,22 (3):367 ~374.
  • 7Xirodimas DP,Chisholm J,Destero JMS,et al.P14ARF promotes accumulation of SUMO-1 conjugated (H) Mdm2[J].FEBS Letters,2002,528(1 -3):207 ~211.
  • 8Frank AJ,Roberto H,Holander A,et al.The TP-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblstona[J].Molecular Brain Res,2004,121 (1 ~ 2):137 ~ 140.
  • 9Lowe SW,Sherr CJ.Tumor suppression by Ink4a-Arf:progress and puzzles[J].Current Opinion in C enetics & Development,2003,13(1):77 ~83.
  • 10Tannapfel A,Busse C,Weinans L,et al.INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas[J].Oncogene,2001,20(48):7104 ~7109.

共引文献33

同被引文献8

  • 1Thomas HC,Lemon SM,Zuckerman AJ.Viral hepatitis[M].3rd ed,Hoboken:Blackwell Publishing,2005:824-840.
  • 2Knipe DM,Howley PM.Field virology[M].5th ed,Philadelphia:Lippincott Williams and Wilkins Immunology,2007:3-4.
  • 3Kanwal F,Hoang T,Kramer JR,et al.Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection[J].Gastroenterology,2011,140(4):1182-1188.
  • 4Hajarizadeh B,Grebely J,DoreG J.Epidemiology and natural history of HCV infection[J].Nat Rev Gastroenterol and Heptology,2013,10(1038):553-562.
  • 5Shepard CW.Global epidemiology of hepatitis C virus infection[J].The Lancet Infectious Disease,2005,5(9):558-567.
  • 6World Health Organization.Global alert and response:hepatitis C[EB/OL].[2013-01-14].http://www.who.int/csr/disease/hepatitis/whocdscsrlyo2003/en/index1.html.
  • 7Hagan H,Snyder N,Hough E,et al.Case-reporting of acute hepatitis B and C among injection drug users[J].J Urban Health,2002,79(4):579-585.
  • 8许可,汤奋扬,王昊鹏,王洁,喻荣彬,邓小昭,张云.血液透析及丙肝病毒感染者F蛋白抗体分析[J].中国公共卫生,2012,28(3):333-335. 被引量:7

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部